chr19-8056209-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_005624.4(CCL25):c.131G>A(p.Arg44Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000115 in 1,571,948 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/23 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_005624.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CCL25 | NM_005624.4 | c.131G>A | p.Arg44Gln | missense_variant | 3/6 | ENST00000315626.6 | NP_005615.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CCL25 | ENST00000315626.6 | c.131G>A | p.Arg44Gln | missense_variant | 3/6 | 2 | NM_005624.4 | ENSP00000324756.6 |
Frequencies
GnomAD3 genomes AF: 0.0000198 AC: 3AN: 151790Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.00000462 AC: 1AN: 216612Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 116622
GnomAD4 exome AF: 0.0000106 AC: 15AN: 1420158Hom.: 0 Cov.: 32 AF XY: 0.0000142 AC XY: 10AN XY: 702020
GnomAD4 genome AF: 0.0000198 AC: 3AN: 151790Hom.: 0 Cov.: 31 AF XY: 0.0000135 AC XY: 1AN XY: 74076
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 21, 2023 | The c.131G>A (p.R44Q) alteration is located in exon 3 (coding exon 2) of the CCL25 gene. This alteration results from a G to A substitution at nucleotide position 131, causing the arginine (R) at amino acid position 44 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at